cropped-logo.png

THE LEADER IN TREATMENT FOR LYMPHEDEMA,
LIPEDEMA AND VENOUS INSUFFICIENCY

  • Home
  • Clinical Information
    • Frequently Asked Questions
    • About Lymphedema
    • About Lipedema
    • About Venous Insufficiency
    • Clinical Research
    • Case Reports
    • Protocols for Lympha Press Therapy
  • Products
    • Product Catalog (PDF)
    • Product Catalog
    • About the Lympha Press® Line
    • PCD-51™
    • PCD-51™
    • PCD-52™
    • Lympha Press® Mini Press
    • Lympha Press Optimal® Plus
    • Lympha Press Optimal® Plus
    • Lympha Press® 201 Max™
    • Our Garments
    • Our Innovative and Unique Garments
  • CME Education
    • Lymphatic and Vascular Disease CME credits
  • Blog
  • Contact Us
  • Contact Us
  • Distributors
Menu
  • Home
  • Clinical Information
    • Frequently Asked Questions
    • About Lymphedema
    • About Lipedema
    • About Venous Insufficiency
    • Clinical Research
    • Case Reports
    • Protocols for Lympha Press Therapy
  • Products
    • Product Catalog (PDF)
    • Product Catalog
    • About the Lympha Press® Line
    • PCD-51™
    • PCD-51™
    • PCD-52™
    • Lympha Press® Mini Press
    • Lympha Press Optimal® Plus
    • Lympha Press Optimal® Plus
    • Lympha Press® 201 Max™
    • Our Garments
    • Our Innovative and Unique Garments
  • CME Education
    • Lymphatic and Vascular Disease CME credits
  • Blog
  • Contact Us
  • Contact Us
  • Distributors

News

The Marker: Mego Afek and COVID-19 related innovation and growth initiatives

June 2, 2020

Mego Afek is honored to have been featured in the exclusive magazine by The Marker, one of Israel’s leading financial publications, covering COVID-19 related innovation and growth initiatives. Barak Hoffer, Mego’s CEO, talked about two important innovative projects we are

Read More »

The Lympha TrackTM mobile application is now available in multiple languages

November 19, 2019

Lympha TrackTM has been recently adopted to multiple languages, so that patients all over the world can easily track lymphedema symptoms and retain their progress with the user-friendly application.Lympha TrackTM is a free application, now available in English, Spanish,German, French

Read More »

Preliminary data shows Lympha Press PCD-51 effective at healing chronic venous stasis ulcers

May 1, 2019

A new study with Lympha Press® PCD-51™ was presented at the Symposium on Advanced Wound Care, Spring, May 2019, San Antonio TX USA…

Read More »
2019 © All rights reserved to Mego Afek ltd.
Specific product models may not be available for sale in all markets. Please contact us for country specific information.
  • Home
  • News and Events
  • Contact Us
  • Contact Us
  • Distributors
  • Mego Afek Global
Menu
  • Home
  • News and Events
  • Contact Us
  • Contact Us
  • Distributors
  • Mego Afek Global

clinical info

  • Frequently-Asked Questions
  • About Lymphedema
  • About Lipedema
  • About Venous Insufficiency
  • Clinical Studies
  • Case reports
  • Protocols for Lympha Press Therapy
Menu
  • Frequently-Asked Questions
  • About Lymphedema
  • About Lipedema
  • About Venous Insufficiency
  • Clinical Studies
  • Case reports
  • Protocols for Lympha Press Therapy

Products

  • Products Catalog (PDF)
  • Products Catalog
  • PCD-51™
  • PCD-51™
  • PCD-52™
  • Lympha Press® 201 Max™
  • Lympha Press Optimal® Plus
  • Lympha Press Optimal® Plus
  • Lympha Press® Mini Press
Menu
  • Products Catalog (PDF)
  • Products Catalog
  • PCD-51™
  • PCD-51™
  • PCD-52™
  • Lympha Press® 201 Max™
  • Lympha Press Optimal® Plus
  • Lympha Press Optimal® Plus
  • Lympha Press® Mini Press
Facebook Youtube Linkedin
Distributor Zone